5-year grant awarded to CVD researchers using AI

The British Heart Foundation (BHF) has awarded researchers at University College London (UCL) £1 million ($1.27 million) to study cardiovascular disease. The funding will be used to bring in a new team of researchers and develop a research center focused on AI.

“Despite the medical advances powered by research, 420 people in the UK still die every day because of heart and circulatory diseases,” Metin Avkiran, BHF associate medical director, said in a prepared statement. “That’s why we’re continuing to invest in research and supporting our scientists to make new life-saving discoveries.”   

According to the statement, BHF’s five-year accelerator grants are designed to “attract and nurture the very best young scientists and doctors in cardiovascular medicine and complementary fields.”

The funding also helps recipients increase their chances of being honored with additional BHF awards in the years ahead.

Michael Walter
Michael Walter, Managing Editor

Michael has more than 18 years of experience as a professional writer and editor. He has written at length about cardiology, radiology, artificial intelligence and other key healthcare topics.

Around the web

The tirzepatide shortage that first began in 2022 has been resolved. Drug companies distributing compounded versions of the popular drug now have two to three more months to distribute their remaining supply.

The 24 members of the House Task Force on AI—12 reps from each party—have posted a 253-page report detailing their bipartisan vision for encouraging innovation while minimizing risks. 

Merck sent Hansoh Pharma, a Chinese biopharmaceutical company, an upfront payment of $112 million to license a new investigational GLP-1 receptor agonist. There could be many more payments to come if certain milestones are met.